Keith Brown, MD; Robin Harbour, PhD; John Petrie, MD, PhD
Potential Conflicts of Interest: Dr. Petrie has provided consultancy or served on trial committees for pharmaceutical companies manufacturing products for the treatment of diabetes, including Bristol-Myers Squibb Pharma, Daaichi Sankyo, GlaxoSmithKline, Novo Nordisk, Pfizer, Roche, and Takeda.
Brown K, Harbour R, Petrie J. Evaluation of Guidelines on Diabetes Medication. Ann Intern Med. 2012;156:752. doi: https://doi.org/10.7326/0003-4819-156-10-201205150-00019
Download citation file:
Published: Ann Intern Med. 2012;156(10):752.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use